Medtronic (MDT) EVP Michelle Quinn Receives Stock Awards

What Happened
Michelle Quinn, EVP, General Counsel and Secretary of Medtronic (MDT), received equity awards on August 3, 2026. The Form 4 reports three grants totaling 67,279 units: 6,346 restricted stock units (RSUs) and two performance-based derivative awards of 15,863 and 45,070 performance share units (PSUs). All grants show $0 per share at grant (typical for compensation awards); no cash was paid.

Key Details

• Transaction date: August 3, 2026; Form 4 filed August 4, 2026 (appears timely).
• Grant amounts and type:
  • 6,346 RSUs (footnote F1) — $0.00 per share.
  • 15,863 PSUs (derivative) (footnotes F2, F4) — $0.00 per share; payout varies with performance (target 15,863 shares, maximum 38,071 shares, minimum could be 0).
  • 45,070 PSUs (derivative) (footnotes F2, F3) — $0.00 per share; tied to performance conditions that will be evaluated/settled on April 27, 2029.
• Shares owned after transaction: not specified in the supplied filing details. See the full Form 4 for total holdings and beneficial ownership.
• Notable footnotes: F1 (RSU vesting 100% on third anniversary), F2 (PSU = contingent right to one share), F3 (performance conditions tied to 4/27/2029), F4 (payout range for the 15,863 PSU grant), F5 (options vesting schedule — not applicable here).

Context
RSUs and PSUs are standard long-term compensation for executives. RSUs convert to shares when they vest; PSUs pay out shares only if performance metrics over the specified period are met, so the ultimate number of shares from PSUs can vary (including possibly zero). These grants are compensation events (awards), not open-market purchases or sales, and therefore are not a direct bullish or bearish trading signal.